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Abstract 
Advances in the fabrication of neuroprosthetic electrodes have attracted considerable interest from 
biomedical researchers. These electrodes are incorporated into a neuroprosthetic device capable of, 
electrically stimulating and recording of neuron activity. Critical to the successful application of these 
electrodes is their biocompatibility, stable conductivity, lower impedance and flexibility whilst maintaining 
appropriate mechanical properties [1] . 
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INTRODUCTION 
Advances in the fabrication of neuroprosthetic electrodes 
have attracted considerable interest from biomedical 
researchers. These electrodes are incorporated into a 
neuroprosthetic device capable of, electrically stimulating 
and recording of neuron activity. Critical to the successful 
application of these electrodes is their biocompatibility, 
stable conductivity, lower impedance and flexibility 
whilst maintaining appropriate mechanical properties [1] . 
A relatively new conducting material, namely organic 
conducting polymers (OCPs), is being utilized in the 
fabrication of electrode structures capable of electrically 
stimulating cells as well as recording cellular activity The 
unique characteristics of OCPs such as biocompatibility 
with higher surface area, compare to traditional 
conductors such as metals, make them an appropriate 
choice to apply in biomedical research [2]. Two types of 
OCPs namely poly(3,4-ethylenedioxythiophene)  
(PEDOT) and polypyrrole (Ppy) have been shown to be  
biocompatible conductors with lower impedance and have 
been employed to coat metal electrode surfaces, resulting 
in an enhancement of electrode/cellular communication 
[3]. Moreover, these structures have widely been used for 
controlled release of a range of biomolecules such as anti-
inflammatory and antibiotic drugs. Fabrication of 
conducting fibers has previously been achieved by us and 
applied to a biomedical application [4]. In the work 
presented here, we discuss the fabrication of OCP 
wetspun fibers (PEDOT:PSS-CHI/Ppy) incorporating the 
antibiotic drug ciprofloxacin hydrochloride (cipro). These 
conducting fibers were tested for their mechanical, 
electrical and drug deliver properties using a range of 
techniques and were shown to possess good electrical and 
mechanical properties. We also show that it is possible to 
control the release of cipro from the conducting fiber and 
that the incorporated and released cipro is still active 
against gram positive and gram negative bacteria. 
APPROACH 
Poly(3,4-ethylenedioxythiophene) poly(styrenesulfonate) 
(PEDOT: PSS) pellets were obtained from Agfa (Orgacon 
dryTM, Lot A6 0000 AC) with water content of 9.8m/m% 
H2O and used as supplied. High molecular weight 
Chitosan (CHI) was purchased from Sigma (>75% 
deacetylation) and Ciprofloxacin Hydrochloride was 
obtained from MP Biomedical Inc. (Lot No. of 8460H) 
with MW = 367.84. Pyrrole monomer was purchased from 
Merck and distilled prior to use and stored at -20oC when 
not in use. Deionised Milli-Q water (18 MΩ cm−1) was 
used to prepare all aqueous solutions. The release of 
Ciprofloxacin hydrochloride was measured in Phosphate 
Buffer Saline (PBS) solution with pH≈ 7.4 prepared by 
dissolving standard PBS tablet (Merck, Germany) in 1 L 
Milli-Q water (18MΩcm-1). Concentrated acetic acid was 
purchased from Sigma and diluted using Milli-Q water. 
The wetspinning method was used to fabricate 
PEDOT:PSS-CHI fibres by injecting PEDOT:PSS with 
concentration of 25 mg/ml into the 1.0 wt% chitosan 
solution. The feeding rate of wetspinning pump was 15 
mL/hr using a 5.0 mL syringe with a detachable needle 
(20 gauge) used as a spinneret. The PEDOT:PSS-CHI 
fibers were washed and dried under tension after 
wetspinning. The second layer (Ppy) was polymerised 
electrochemically onto the PEDOT:PSS-CHI fibre, from a 
0.2 M pyrrole monomer containing 5.0 mM Ciprofloxacin 
hydrochloride in MilliQ water. The electrochemical 
polymerisation was performed under galvanostatic mode 
utilizing a platinum mesh (counter electrode), Ag/AgCl 
(reference electrode) and the PEDOT:PSS-CHI fiber as 
the working electrode. The release of ciprofloxacin was 
measured by UV.vis spectroscopy at a wavelength of 
270nm. For electrically stimulated release, the cell 
contained a platinum mesh auxiliary, Ag/AgCl reference 
and the PEDOT:PSS-CHI/Ppy.Cipro  fiber. Samples of 
release mediums were collected over three days with each 
aliquot being collected and replaced with fresh PBS. The 
aliquots were kept at 2 oC until drug measurements were 
performed.  
RESULTS AND DISCUSSION 
The PEDOT:PSS-CHI fibres were wetspun by the 
injection of a PEDOT:PSS solution into a solution of 
chitosan (1 wt%) and the fiber formation occurring by the 
reaction between negatively charge of PSS and positively 
charge of amine group in chitosan. The morphology of 
fibers was analyzed using scanning electron microscopy 
(SEM) and show a compact and dense structure with 
average diameter of 56 ± 7 m (Fig. 1A – white arrow).  
 
  
Fig 1. (A) Scanning electron microscopy (SEM) image of 
PEDOT:PSS-CHI fibre without (white arrow) and with (black 
arrow) the Ppy.Cipro layer. (B) SEM image of cross-section of 
fibre. (The white lines show the Ppy.Cipro layer) [5]. 
The electrochemistry and conductivity of these fibres was 
analyzed (Fig 2A and B) and was shown to be suitable to 
allow a second conducting polymer layer to be 
electrochemically deposited onto. The second layer was 
composed of polypyrrole doped with the antibiotic 
ciprofloxacin (Ppy.Cipro). The SEM in Fig 1A and 1B 
shows a change in morphology of fibres before and after 
polymerisation of second layer.  
A B
 
The release of ciprofloxacin hydrochloride from 
Ppy.Cipro under passive and electrically stimulated 
conditions was measured by UV.vis over 3 days (Fig. 3). 
The non-stimulated (passive) release showed most of 
ciprofloxacin was released during first 9 hours followed 
by a plateau. While, the release of ciprofloxacin increased 
in higher concentration and longer time points by 
electrical stimulation. 
 
 
 
 
Fig 3. (A) release profile of Cipro release during oxidized,  
reduced and passive state of conducting polymer within 72h. B) 
Release profile of Cipro with switching between oxidized and 
reduced state of Ppy layer. 
 
CONCLUSION 
Conducting polymer fibres have been fabricated via wet-
spinning method and represents solid and promising 
structures to incorporate antibiotic drug. The release of 
ciprofloxacin has been investigated under passive and 
stimulated conditions. The results showed the capability 
of these novel fibres to control drug release in specific 
timeframe required and demonstrated promises in drug 
delivery applications.  
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